Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (781-790 of 889) with videos related to

Pageof 89
Sort By:
BMC Medicine|October 8, 2024
Measuring internalized health-related stigma across health conditions: development and validation of the I-HEARTS ScaleRebecca L Pearl, Yulin Li, Laurie C Groshon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 25, 2020
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosisAndrew R Romeo, William M Rowles, Erica S Schleimer, et al.
Journal of the American Academy of Dermatology|November 19, 2025
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsAndrew Blauvelt, Bruce E Strober, Guy S Eakin, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Circulation Research|December 21, 2018
Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in PsoriasisAlexander V Sorokin, Kazuhiko Kotani, Youssef A Elnabawi, et al.
Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 21, 2026
Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot StudyJennifer B Mason, Christina Johnson, Nkiru Ogbuefi, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Gastrointestinal Endoscopy|May 26, 2001
Reusable biopsy forceps: a prospective evaluation of cleaning, function, adequacy of tissue specimen, and durabilityR A Kozarek, F M Attia, S E Sumida, et al.
Circulation. Cardiovascular Imaging|September 15, 2020
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational StudyHarry Choi, Domingo E Uceda, Amit K Dey, et al.
Pageof 89

Showing results (781-790 of 889) with videos related to

Sort By:
Pageof 89
BMC Medicine|October 8, 2024
Measuring internalized health-related stigma across health conditions: development and validation of the I-HEARTS ScaleRebecca L Pearl, Yulin Li, Laurie C Groshon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 25, 2020
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosisAndrew R Romeo, William M Rowles, Erica S Schleimer, et al.
Journal of the American Academy of Dermatology|November 19, 2025
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsAndrew Blauvelt, Bruce E Strober, Guy S Eakin, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Circulation Research|December 21, 2018
Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in PsoriasisAlexander V Sorokin, Kazuhiko Kotani, Youssef A Elnabawi, et al.
Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 21, 2026
Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot StudyJennifer B Mason, Christina Johnson, Nkiru Ogbuefi, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Gastrointestinal Endoscopy|May 26, 2001
Reusable biopsy forceps: a prospective evaluation of cleaning, function, adequacy of tissue specimen, and durabilityR A Kozarek, F M Attia, S E Sumida, et al.
Circulation. Cardiovascular Imaging|September 15, 2020
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational StudyHarry Choi, Domingo E Uceda, Amit K Dey, et al.
Pageof 89